U.S. Next Generation Sequencing Market (2025 - 2033) Size, Share & Trends Analysis Report By Technology, By Product, By Application, By Workflow (Pre-sequencing, Sequencing, Data Analysis), By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Technology
                        1.1.2. Product
                        1.1.3. Application
                        1.1.4. Workflow
                        1.1.5. End-use
                        1.1.6. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights
Chapter 3. U.S. Next Generation Sequencing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Rising incidence of cancer and genetic disorders
                            3.2.1.2. Advancements in sequencing technologies
                        3.2.2. Market restraint analysis
                            3.2.2.1. Lack of computational efficiency for data management
                            3.2.2.2. Non–value-based NGS reimbursement policy and regulation status
                            3.2.2.3. Challenges associated with NGS implementation.
                    3.3. U.S. Next Generation Sequencing Market Analysis Tools
                        3.3.1. SWOT analysis; by factor (political & legal, economic, and technological)
                        3.3.2. Porter’s Five Forces Analysis
Chapter 4. U.S. Next Generation Sequencing Market: Technology Business Analysis
                    4.1. Next Generation Sequencing Market: Technology Movement Analysis
                    4.2. Targeted Sequencing & Resequencing
                        4.2.1. Targeted Sequencing & Resequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)
                            4.2.1.1. DNA-based targeted sequencing & resequencing
                                4.2.1.1.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
                            4.2.1.2. RNA-based targeted sequencing & resequencing
                                4.2.1.2.1. RNA -based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
                    4.3. Whole Genome Sequencing
                        4.3.1. Whole Genome Sequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)
                    4.4. Whole Exome Sequencing
                        4.4.1. Whole Exome Sequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)
Chapter 5. U.S. Next Generation Sequencing Market: Product Business Analysis
                    5.1. Next Generation Sequencing Market: Product Movement Analysis
                    5.2. Platforms
                        5.2.1. Platforms Market Estimates And Forecast, 2021 - 2033 (USD Million)
                            5.2.1.1. Sequencing
                                5.2.1.1.1. Sequencing platforms market estimates and forecast, 2021 - 2033 (USD Million)
                            5.2.1.2. Data Analysis
                                5.2.1.2.1. Data analysis platforms market estimates and forecast, 2021 - 2033 (USD Million
                    5.3. Consumables
                        5.3.1. Consumables market estimates and forecast, 2021 - 2033 (USD million)
                        5.3.2. Sample Preparation
                            5.3.2.1. Sample preparation market estimates and forecast, 2021 - 2033 (USD Million)
                        5.3.3. Target Enrichment
                            5.3.3.1. Target enrichment market estimates and forecast, 2021 - 2033 (USD Million)
                        5.3.4. Others
                            5.3.4.1. Others market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 6. U.S. Next Generation Sequencing Market: Application Business Analysis
                    6.1. Next Generation Sequencing Market: Application Movement Analysis
                    6.2. Oncology
                        6.2.1. Oncology Market Estimates And Forecast, 2021 - 2033 (USD Million)
                        6.2.2. Diagnostics & Screening
                            6.2.2.1. Diagnostics & screening market estimates and forecast, 2021 - 2033 (USD Million)
                            6.2.2.2. Oncology screening
                                6.2.2.2.1. Oncology screening market estimates and forecast, 2021 - 2033 (USD Million)
                                6.2.2.2.2. Sporadic cancer screening market estimates and forecast, 2021 - 2033 (USD Million)
                                6.2.2.2.3. Inherited cancer screening market estimates and forecast, 2021 - 2033 (USD Million)
                            6.2.2.3. Companion diagnostics
                                6.2.2.3.1. Companion diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
                            6.2.2.4. Other diagnostics
                                6.2.2.4.1. Other diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
                        6.2.3. Research Studies
                            6.2.3.1. Research studies market estimates and forecast, 2021 - 2033 (USD Million)
                    6.3. Clinical investigation
                        6.3.1. Clinical investigation market estimates and forecast, 2021 - 2033 (USD Million)
                        6.3.2. Infectious Diseases
                            6.3.2.1. Infectious diseases market estimates and forecast, 2021 - 2033 (USD Million)
                        6.3.3. Idiopathic Diseases
                            6.3.3.1. Idiopathic diseases market estimates and forecast, 2021 - 2033 (USD Million)
                        6.3.4. Inherited Diseases
                            6.3.4.1. Inherited diseases market estimates and forecast, 2021 - 2033 (USD Million)
                        6.3.5. Non-Communicable/Other Diseases
                            6.3.5.1. Non-communicable/other diseases market estimates and forecast, 2021 - 2033 (USD Million)
                    6.4. Reproductive Health
                        6.4.1. Reproductive Health Market Estimates And Forecast, 2021 - 2033 (USD Million)
                        6.4.2. NIPT
                            6.4.2.1. NIPT market estimates and forecast, 2021 - 2033 (USD Million)
                            6.4.2.2. Aneuploidy
                                6.4.2.2.1. Aneuploidy market estimates and forecast, 2021 - 2033 (USD Million)
                            6.4.2.3. Microdeletions
                                6.4.2.3.1. Microdeletions market estimates and forecast, 2021 - 2033 (USD Million)
                        6.4.3. PGT
                            6.4.3.1. PGT market estimates and forecast, 2021 - 2033 (USD Million)
                        6.4.4. Newborn Genetic Screening
                            6.4.4.1. Newborn genetic screening market estimates and forecast, 2021 - 2033 (USD Million)
                        6.4.5. Single Gene Analysis
                            6.4.5.1. Single gene analysis market estimates and forecast, 2021 - 2033 (USD Million)
                    6.5. HLA Typing/Immune System Monitoring
                        6.5.1. HLA Typing/Immune System Monitoring Market Estimates And Forecast, 2021 - 2033 (USD Million)
                    6.6. Metagenomics, Epidemiology & Drug Development
                        6.6.1. Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2021 - 2033 (USD Million)
                    6.7. Agrigenomics & Forensics
                        6.7.1. Agrigenomics & Forensics Market Estimates And Forecast, 2021 - 2033 (USD Million)
                    6.8. Consumer Genomics
                        6.8.1. Consumer Genomics Market Estimates And Forecast, 2021 - 2033 (USD Million)
Chapter 7. U.S. Next Generation Sequencing Market: Workflow Business Analysis
                    7.1. Next Generation Sequencing Market: Workflow Movement Analysis
                    7.2. Pre sequencing
                        7.2.1. Pre-Sequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)
                            7.2.1.1. Nucleic acid extraction
                                7.2.1.1.1. Nucleic acid extraction market estimates and forecast, 2021 - 2033 (USD Million)
                            7.2.1.2. Library preparation
                                7.2.1.2.1. Library preparation market estimates and forecast, 2021 - 2033 (USD Million)
                    7.3. Sequencing
                        7.3.1. Sequencing Market Estimates And Forecast, 2021 - 2033 (USD Million)
                    7.4. Data Analysis
                        7.4.1. Data Analysis Market Estimates And Forecast, 2021 - 2033 (USD Million)
                        7.4.2. Primary Data NGS Analysis
                            7.4.2.1. Primary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
                        7.4.3. Secondary Data Analysis
                            7.4.3.1. Secondary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
                        7.4.4. Tertiary Data Analysis
                            7.4.4.1. Tertiary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 8. U.S. Next Generation Sequencing Market: End Use Business Analysis
                    8.1. Next Generation Sequencing Market: End-use Movement Analysis
                    8.2. Academic Research
                        8.2.1. Academic Research Market Estimates And Forecast, 2021 - 2033 (USD Million)
                    8.3. Clinical Research
                        8.3.1. Clinical Research Market Estimates And Forecast, 2021 - 2033 (USD Million)
                    8.4. Hospitals & Clinics
                        8.4.1. Hospitals & Clinics Market Estimates And Forecast, 2021 - 2033 (USD Million)
                    8.5. Pharmaceutical & Biotech Entities
                        8.5.1. Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2021 - 2033 (USD Million)
                    8.6. Other Users
                        8.6.1. Other Users Market Estimates And Forecast, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Recent Developments & Impact Analysis, By Key Market Participants
                    9.2. Company/Competition Categorization
                    9.3. Market position analysis, 2024
                    9.4. Participants Overview
                        9.4.1. Illumina, Inc
                            9.4.1.1. Company overview
                            9.4.1.2. Financial performance
                            9.4.1.3. Product benchmarking
                            9.4.1.4. Strategic initiatives
                        9.4.2. Thermo Fisher Scientific Inc.
                            9.4.2.1. Company overview
                            9.4.2.2. Financial performance
                            9.4.2.3. Product benchmarking
                            9.4.2.4. Strategic initiatives
                        9.4.3. Eurofins Scientific SE
                            9.4.3.1. Company overview
                            9.4.3.2. Financial performance
                            9.4.3.3. Product benchmarking
                            9.4.3.4. Strategic initiatives
                        9.4.4. Eurofins Scientific SE
                            9.4.4.1. Company overview
                            9.4.4.2. Financial performance
                            9.4.4.3. Product benchmarking
                            9.4.4.4. Strategic initiatives
                        9.4.5. QIAGEN
                            9.4.5.1. Company overview
                            9.4.5.2. Financial performance
                            9.4.5.3. Product benchmarking
                            9.4.5.4. Strategic initiatives
                        9.4.6. Quest Diagnostics Incorporated
                            9.4.6.1. Company overview
                            9.4.6.2. Financial performance
                            9.4.6.3. Product benchmarking
                            9.4.6.4. Strategic initiatives
                        9.4.7. Azenta Life Sciences (GENEWIZ)
                            9.4.7.1. Company overview
                            9.4.7.2. Financial performance
                            9.4.7.3. Product benchmarking
                            9.4.7.4. Strategic initiatives
                        9.4.8. NanoString
                            9.4.8.1. Company overview
                            9.4.8.2. Financial performance
                            9.4.8.3. Product benchmarking
                            9.4.8.4. Strategic initiatives
                        9.4.9. PacBio
                            9.4.9.1. Company overview
                            9.4.9.2. Financial performance
                            9.4.9.3. Product benchmarking
                            9.4.9.4. Strategic initiatives
                        9.4.10. bioMérieux
                            9.4.10.1. Company overview
                            9.4.10.2. Financial performance
                            9.4.10.3. Product benchmarking
                            9.4.10.4. Strategic initiatives
                        9.4.11. BGI Group
                            9.4.11.1. Company overview
                            9.4.11.2. Financial performance
                            9.4.11.3. Product benchmarking
                            9.4.11.4. Strategic initiatives
                        9.4.12. F. Hoffmann-La Roche Ltd
                            9.4.12.1. Company overview
                            9.4.12.2. Financial performance
                            9.4.12.3. Product benchmarking
                            9.4.12.4. Strategic initiatives
                        9.4.13. ARUP Laboratories
                            9.4.13.1. Company overview
                            9.4.13.2. Financial performance
                            9.4.13.3. Product benchmarking
                            9.4.13.4. Strategic initiatives
                        9.4.14. Novogene Co, Ltd.
                            9.4.14.1. Company overview
                            9.4.14.2. Financial performance
                            9.4.14.3. Product benchmarking
                            9.4.14.4. Strategic initiatives
                        9.4.15. Gene by Gene Ltd.
                            9.4.15.1. Company overview
                            9.4.15.2. Financial performance
                            9.4.15.3. Product benchmarking
                            9.4.15.4. Strategic initiatives
                        9.4.16. Lucigen Corporation
                            9.4.16.1. Company overview
                            9.4.16.2. Financial performance
                            9.4.16.3. Product benchmarking
                            9.4.16.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. next generation sequencing market, by technology, 2021 - 2033 (USD Million)
Table 4 U.S. next generation sequencing market, by product, 2021 - 2033 (USD Million)
Table 5 U.S. next generation sequencing market, by application, 2021 - 2033 (USD Million)
Table 6 U.S. next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
Table 7 U.S. next generation sequencing market, by End Use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 U.S. next generation sequencing market: market outlook
Fig. 7 U.S. next generation sequencing competitive insights.
Fig. 8 Parent market outlook
Fig. 9 Related/ancillary market outlook.
Fig. 10 Penetration and growth prospect mapping
Fig. 11 Industry value chain analysis
Fig. 12 U.S. next generation sequencing market driver impact
Fig. 13 U.S. next generation sequencing market restraint impact
Fig. 14 U.S. next generation sequencing market strategic initiatives analysis
Fig. 15 U.S. next generation sequencing market: Technology movement analysis
Fig. 16 U.S. next generation sequencing market: Technology outlook and key takeaways
Fig. 17 Targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 18 DNA-based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 19 RNA -based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 20 Whole genome sequencing market estimates and forecast, 2021-2033 (USD Million)
Fig. 21 Whole exome sequencing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 22 U.S. Next-generation sequencing market: Product outlook key takeaways
Fig. 23 U.S. Next-generation sequencing market: Product movement analysis
Fig. 24 Platforms market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 25 Sequencing platforms market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 26 Data analysis platforms market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 27 Consumables market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 28 Sample preparation market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 29 Target enrichment market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 30 Others market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 31 U.S. next generation sequencing Market: Application Movement Analysis
Fig. 32 U.S. next generation sequencing market: Application outlook and key takeaways
Fig. 33 Oncology market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 34 Diagnostics & screening market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 35 Oncology screening market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 36 Sporadic cancer screening market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 37 Inherited cancer screening market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 38 Companion diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 39 Other diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 40 Research studies market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 41 Clinical investigation market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 42 Infectious diseases market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 43 Idiopathic diseases market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 44 Inherited diseases market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 45 Non-communicable/other diseases market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 46 Reproductive health market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 47 NIPT market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 48 Aneuploidy market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 49 Microdeletions market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 50 PGT market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 51 Newborn genetic screening market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 52 Single gene analysis market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 53 HLA typing/immune system monitoring market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 54 Metagenomics, epidemiology & drug development market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 55 Agrigenomics & forensics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 56 Consumer genomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 57 U.S. next generation sequencing market: workflow movement analysis
Fig. 58 U.S. next generation sequencing market: workflow outlook and key takeaways
Fig. 59 Pre-sequencing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 60 Nucleic acid extraction market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 61 Library preparation market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 62 Automated library preparation market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 63 Sequencing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 64 Data analysis market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 65 Primary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 66 Secondary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 67 Tertiary data analysis market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 68 U.S. Next generation sequencing market End Use outlook key takeaways
Fig. 69 U.S. Next-generation sequencing market: End Use movement analysis
Fig. 70 Academic research market estimates and forecast, 2021 - 2033 (USD Million))
Fig. 71 Clinical research market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 72 Hospitals & clinics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 73 Pharmaceutical & biotech entities market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 74 Other users market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 75 Market share of key market players- U.S. next generation sequencing market